
Twelve years of experience with miglustat in the treatment of type 1 Gaucher disease: The Spanish ZAGAL project
Keywords: آنزیم جایگزین درمان; BUA; broadband ultrasound attenuation; BMD; bone mineral density; CCL18/PARC; chemokine (C-C motif) ligand 18/pulmonary and activation-regulated chemokine; CHITO; chitotriosidase; ERT; enzyme replacement therapy; DXA; dual X-ray absorptiometry; EMG; elect